Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastroesophageal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06926374
What this trial is testing

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

Who this might be right for
Colorectal CarcinomaRectal ProlapseProstate Cancer (Adenocarcinoma)+7 more
Chinese University of Hong Kong 90
Not applicableStudy completedNCT02121626
What this trial is testing

The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms"

Who this might be right for
Cancer
Royal Marsden NHS Foundation Trust 248
Not applicableNot Yet RecruitingNCT07625735
What this trial is testing

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction AdenocarcinomaMismatch Repair Deficient or MSI-High Solid TumorsLymph Node Metastasis+1 more
Shanghai Zhongshan Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Study completedNCT03686488
What this trial is testing

TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 23
Not applicableActive Not RecruitingNCT06640153
What this trial is testing

MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer, Gastroesophageal Junction Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Not applicableLooking for participantsNCT00590239
What this trial is testing

Barrett's Esophagus Related Neoplasia (BERN) Project

Who this might be right for
Barrett's EsophagusNeoplasmsGastroesophageal Reflux
Midwest Biomedical Research 150
Testing effectiveness (Phase 2)Looking for participantsNCT05687357
What this trial is testing

Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 140
Not applicableStudy completedNCT00445653
What this trial is testing

Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding

Who this might be right for
Precancerous Condition
Massachusetts General Hospital 170
Not applicableUnknownNCT04385641
What this trial is testing

Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer

Who this might be right for
Advanced Gastric CancerGastroesophageal Cancer
Shandong Golden Brick Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07257380
What this trial is testing

Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospital 90
Not applicableNot Yet RecruitingNCT07144995
What this trial is testing

MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma

Who this might be right for
Advanced Gastric CancerGastroesophageal Junction AdenocarcinomaFruquintinib+1 more
Sun Yat-sen University 1,143
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06385873
What this trial is testing

RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 32
Post-approval studies (Phase 4)UnknownNCT01038154
What this trial is testing

Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer

Who this might be right for
Esophageal CancerStomach Cancer
Hospital Donostia 146
Testing effectiveness (Phase 2)Study completedNCT02999295
What this trial is testing

Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Region (GEJ) Cancer
National Cancer Center, Japan 46
Testing effectiveness (Phase 2)Study completedNCT03852251
What this trial is testing

AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaAdvanced Solid TumorsGastroesophageal Junction Adenocarcinoma
Akeso 338
Testing effectiveness (Phase 2)Study completedNCT03724851
What this trial is testing

Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer

Who this might be right for
Metastatic Colorectal CancerGastric CancerGastroesophageal Junction Adenocarcinoma
MedPacto, Inc. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07176312
What this trial is testing

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Who this might be right for
Gastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Not applicableStudy completedNCT01434485
What this trial is testing

Nexium Capsules Clinical Experience Investigation

Who this might be right for
Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Oesophagitis,"Non-erosive Reflux Disease, Zollinger-Ellison Syndrome
AstraZeneca 3,691
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Next Page